Actualités Orefinders Resources Inc - ORX | Actions TSX Venture Exchange

Life Science Investor Forum Agenda Announced for June 22nd

NEW YORK, June 20, 2023 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor...

Orexo to Webcast Live at VirtualInvestorConferences.com December 15th

MORRISTOWN, N.J., Dec. 14, 2022 (GLOBE NEWSWIRE) -- Orexo (STO:ORX) (OTCQX:ORXOY), which develops improved...

KCSA Mental Health Virtual Investor Conference Agenda Announced for December 15th

NEW YORK, Dec. 13, 2022 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor...

Life Sciences Companies Investor Presentations Now Available for On-Demand Viewing

NEW YORK, June 29, 2020 (GLOBE NEWSWIRE) -- Life Sciences Investor Forum today announced that the...

Virtual Conference for Life Sciences Companies Broadcast Live June 25, 2020

NEW YORK, June 23, 2020 (GLOBE NEWSWIRE) -- Life Sciences Investor Forum today announced the agenda for its...

Virtual Conference for Life Sciences Companies and Investors Broadcast Live March 26, 2020

NEW YORK, March 24, 2020 (GLOBE NEWSWIRE) -- Life Sciences Investor Forum today announced the agenda for its...

Kerr Mines sells remaining Northern Ontario land package, bolsters shareholder value

TORONTO, Aug. 20, 2018 (GLOBE NEWSWIRE) -- Kerr Mines Inc. (TSX:KER) (OTC:KERMF) (FRA:7AZ1) (“Kerr” or the...

Orexo: Favorable outcome from Zubsolv® patent infringement litigation against Actavis

Regulatory News: Orexo AB (publ.) (STO:ORX) announces that the United States District Court for the District of Delaware ruled in Orexo’s...

Number of shares and votes in Orexo

The number of shares and votes in Orexo AB has changed as a result of the exercise of warrants in connection with the company’s incentive...

Orexo: Interim Report January-September 2016

Regulatory News: Orexo (STO:ORX) Strong Zubsolv® and Abstral® revenue growth. Third quarter 2016 · Total net revenues MSEK...

Orexo: FDA Approves Unique Low Dosage of Zubsolv®

Regulatory News: Orexo (STO:ORX) Orexo AB (publ.) announced today that it has received approval from the US Food and Drug...

Mundipharma and Orexo Announce EU Regulatory Submission for Zubsolv®

· Mundipharma and Orexo make first EU regulatory submission for Zubsolv® (buprenorphine and naloxone) sublingual tablet · Zubsolv was...

Number of Shares and Votes in Orexo

The number of shares and votes in Orexo AB (STO:ORX) has changed as a result of the exercise of warrants in connection with the company’s...

Orexo Appoints Nomination Committee and Publishes Financial Calendar 2016/2017

Regulatory News: Orexo (STO:ORX) Prior to the Annual General Meeting 2017, Orexo appoints a Nomination Committee which represents...

Orexo: Issue and Repurchase of Class C Shares

Orexo AB (publ.) (STO:ORX) announces that the company has resolved to issue and immediately thereafter repurchase 200,000 class C shares. The...

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Orefinders Resources Inc (ORX)

Votre Hub pour des idées et discussions en direct en temps réel

ORX Actualités

Life Science Investor Forum Agenda Announced for June 22nd

Orexo to Webcast Live at VirtualInvestorConferences.com December 15th

KCSA Mental Health Virtual Investor Conference Agenda Announced for December 15th

Life Sciences Companies Investor Presentations Now Available for On-Demand Viewing

Virtual Conference for Life Sciences Companies Broadcast Live June 25, 2020

Virtual Conference for Life Sciences Companies and Investors Broadcast Live March 26, 2020

Kerr Mines sells remaining Northern Ontario land package, bolsters shareholder value

Orexo: Favorable outcome from Zubsolv® patent infringement litigation against Actavis

Number of shares and votes in Orexo

Orexo: Interim Report January-September 2016

Orexo: FDA Approves Unique Low Dosage of Zubsolv®

Mundipharma and Orexo Announce EU Regulatory Submission for Zubsolv®

Number of Shares and Votes in Orexo

Orexo Appoints Nomination Committee and Publishes Financial Calendar 2016/2017

Orexo: Issue and Repurchase of Class C Shares

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Orefinders Resources Inc (ORX) Actualités

Orefinders Resources Inc (ORX)

Votre Hub pour des idées et discussions en direct en temps réel

ORX Actualités

Life Science Investor Forum Agenda Announced for June 22nd

Orexo to Webcast Live at VirtualInvestorConferences.com December 15th

KCSA Mental Health Virtual Investor Conference Agenda Announced for December 15th

Life Sciences Companies Investor Presentations Now Available for On-Demand Viewing

Virtual Conference for Life Sciences Companies Broadcast Live June 25, 2020

Virtual Conference for Life Sciences Companies and Investors Broadcast Live March 26, 2020

Kerr Mines sells remaining Northern Ontario land package, bolsters shareholder value

Orexo: Favorable outcome from Zubsolv® patent infringement litigation against Actavis

Number of shares and votes in Orexo

Orexo: Interim Report January-September 2016

Orexo: FDA Approves Unique Low Dosage of Zubsolv®

Mundipharma and Orexo Announce EU Regulatory Submission for Zubsolv®

Number of Shares and Votes in Orexo

Orexo Appoints Nomination Committee and Publishes Financial Calendar 2016/2017

Orexo: Issue and Repurchase of Class C Shares

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application